[1] |
The State Council Gazette of the People's Republic of China. Town water supply: Opinions of the General Office of the State Council on speeding up the development of seawater desalination industry. 2012. |
[2] |
Chang-Hai LI, Zhang YX. Discussion on seawater desalination technology and its application. Electric Power Technology & Environmental Protection, 2011; 27, 48-51. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=dlhjbh201101014 |
[3] |
Liu YH, Feng HJ, Yun-Hong GE. Analysis on Characteristics and Use of Product Water from Seawater Desalination Plants. China Water & Wastewater, 2009; 25, 88-92. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgjsps200914024 |
[4] |
Eninke Q. Encyclopedia of chemistry technology. Encyclopedia of chemistry technology. New York: Marcel Dekker Inc, 1963; 776-7. |
[5] |
Ge CC, Wang YS, Yu HW, et al. Study On Foam and Antifoaming agent. Development & Application of Materials, 2010; 25, 81-5. http://d.old.wanfangdata.com.cn/Periodical/jxhg201002019 |
[6] |
Zhu TY, Mao LI, Cheng L, et al. Types and Characteristics Introduction of Antifoaming Agent. Lubricating Oil, 2017; 32, 23-5. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=rhy201706005 |
[7] |
Chang GR, Chen GP, Chen L, et al. Preparation and application of silicon defoaming agent modified by polyether. Applied Chemical Industry, 2012; 41, 232-6. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=sxhg201202014 |
[8] |
Li Y. Matters needing attention in the evaluation and application of defoamer. Paper and Papermaking, 2000; 4, 60-1. |
[9] |
Wu HL, Yang BN. Toxicity of LES defoamer. Cancer Aberration: Mutation, 1992; 4, 26-8. |
[10] |
Ye YM. Food additives and their safety. Drug Evaluation, 2005; 2, 81-90. http://d.old.wanfangdata.com.cn/Periodical/zxqykj200920047 |
[11] |
Linyong Y, Lilong A, Chunliang C. Study on the Toxicological Safety of a Common Type of Water-Based Defamer. Asian Journal of Ecotoxicology, 2010; 5, 143-8. |
[12] |
Foundation NS. NSF/ANSI 60-2012. Drinking Water Treatment Chemicals-Health Effects. The United States, 2012. |
[13] |
Ministry of Health, People's Republic of China. Hygienic safety assessment of chemical treatment agents for drinking water. Beijing:China Standard Press, 2012. |
[14] |
Wang Luyao DL, Zhao Kangfeng, Gu Wen, et al. Determine the cytotoxicity of scale inhibitor in seawater desalting by real-time cell analysis. Journal of Toxicology, 2018; 32, 131-4. |
[15] |
Organization for Economic Co-operation and Development. Guidelines for the testing of chemicals. 2018. |
[16] |
Lu Ya-qing, Zhang Nan, Wang Wen-zong, et al. Study on defoaming mechanism of polyether modified polysiloxane compounds. Silicone Material, 2010; 24, 80-4. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=yjgcljyy201002003 |
[17] |
Luo Qian. Synthesis and properties of polyether modified silicone defoaming agent, Beijing: University of Chinese Academy of Sciences, 2014. |
[18] |
Wang Xixu, Zhu Xuefeng, Zuo Shengli, et al. Application of Defoaming Agent in Seawater Circulating Cooling System of Coastal NPPs. Radiation Protection Bulletin, 2015; 2, 21-4. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=fsfhtx201502006 |
[19] |
Sun GF. Occupational health and occupational medicine. Beijing:People's Health Publishing House, 2012. |
[20] |
Ye Weifa, Zhong Zhenyi. Hepatobiliary Diagnosis. Tianjin:Tianjin science and technology press, 1997. |
[21] |
Evans GO. Animal Clinical Chemistry. Control and Reporting Center Press, 1996. |
[22] |
Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 2010; 115, 168-86. doi: 10.1182/blood-2009-06-225565 |
[23] |
Isenhart CE, Brandt JT. Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol, 1993; 99, 324. doi: 10.1093/ajcp/99.3.324 |
[24] |
Li Ping, Yang Renchi. Progress in the study of cellular immune mechanism of idiopathic thrombocytopenic purpura. Journal of Clinical Internal Medicine, 2010; 27, 365-8. |
[25] |
Su Liping, Hao Guoping. Study on cellular immune function in patients with chronic idiopathic thrombocytopenic purpura. Chinese Journal of Hematology, 2000; 21, 144-4. |
[26] |
Xu Youmei, Xu Xiao. The effect of menstrual cycle on Hemorheology. Jiangxi Medical Journal, 1995; 3, 129-33. (In Chinese) http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xdzxyjhzz201714010 |
[27] |
Berglund U, Wallentin L, Von SH. Platelet function and plasma fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of myocardial infarction. Thromb Haemost, 1988; 60, 21-4. doi: 10.1055/s-0038-1647627 |
[28] |
Faraday N, Goldschmidtclermont PJ, Bray PF. Gender differences in platelet GPⅡb-Ⅲa activation. Thromb Haemost, 1997; 77, 748-54. doi: 10.1055/s-0038-1656045 |
[29] |
Lommatzsch M, Zingler D, Schuhbaeck K, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging, 2005; 26, 115-23. doi: 10.1016/j.neurobiolaging.2004.03.002 |
[30] |
Simon LM, Edelstein LC, Nagalla S, et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood, 2014; 123, e37. doi: 10.1182/blood-2013-12-544692 |
[31] |
Bueno L, Beaufrand C, Theodorou V, et al. Influence of simethicone and alverine on stress-induced alterations of colonic permeability and sensitivity in rats:beneficial effect of their association. Journal of Pharmacy & Pharmacology, 2013; 65, 567-73. |
[32] |
Clayton Gd CF. Patty's industrial hygiene and toxicology(4th ed). New York: John Wiley and Sons Inc, 1994. |